Testosterone pellet implants and migraine headaches: A pilot study
Maturitas, 03/23/2012Glaser R et al.
Continuous testosterone was effective therapy in reducing the severity of migraine headaches in both pre– and post–menopausal women.
Twenty–seven women with a history of documented migraine headache were asked to rate their headache severity using a five–point scale at baseline (prior to therapy); and again, 3months following treatment with testosterone implants. Improvement in headache severity was noted by 92% of patients and the mean level of improvement was statistically significant (3.3 on a 5 point scale).
Improvement in headache severity was noted by 92% of patients and the mean level of improvement was statistically significant (3.3 on a 5 point scale).
There was no difference in the level of improvement between pre– and post–menopausal cohorts.
Seventy–four percent of patients reported a headache severity score of ‘0’ (none) on testosterone implant therapy for the 3–month treatment period.
MDLinx connects healthcare professionals and patients to tomorrow's important medical news, while providing the pharmaceutical and healthcare industries with highly targeted interactive marketing, education, content, and medical research solutions.